Severe antibody-mediated rejection following IVIG infusion in a kidney transplant recipient with BK-virus nephropathy (Q44077279)

29 November 2017

Severe antibody-mediated rejection following IVIG infusion in a kidney transplant recipient with BK-virus nephropathy (English)

1 reference

29 November 2017

R Mainra

1

1 reference

29 November 2017

Q Xu

2

1 reference

29 November 2017

R Chibbar

3

1 reference

29 November 2017

A Hassan

4

1 reference

29 November 2017

A Shoker

5

1 reference

29 November 2017

language of work or name

1 reference

15 May 2013

1 reference

29 November 2017

Transplant Immunology

1 reference

29 November 2017

28

1 reference

29 November 2017

4

1 reference

29 November 2017

145-147

1 reference

Clinical aspects of intravenous immunoglobulin use in solid organ transplant recipients

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2013.05.004

Intravenous immunoglobulin a natural regulator of immunity and inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2013.05.004

Regulation of immunity and inflammation by intravenous immunoglobulin: relevance to solid organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2013.05.004

Utility of intravenous immune globulin in kidney transplantation: efficacy, safety, and cost implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2013.05.004

Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: one-year follow-up of renal allograft recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2013.05.004

Intravenous immunoglobulin therapy in the treatment of BK viremia and nephropathy in pediatric renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2013.05.004

Multicenter crossover comparison of the safety and efficacy of Intraglobin-F with Gamimune-N, Sandoglobulin, and Gammagard in patients with primary immunodeficiency diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2013.05.004

International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2013.05.004

Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2013.05.004

Banff 2011 Meeting report: new concepts in antibody-mediated rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2013.05.004

De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2013.05.004

Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2013.05.004

Safety and adverse events profiles of intravenous gammaglobulin products used for immunomodulation: a single-center experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2013.05.004

High-dosage intravenous immunoglobulin-associated macrovacuoles are associated with chronic tubulointerstitial lesion worsening in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2013.05.004

Proposed relationship between intravenous immunoglobulin and thrombosis in renal transplant recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2013.05.004

Acute hemolysis after high-dose intravenous immunoglobulin therapy in highly HLA sensitized patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2013.05.004

10.1016/J.TRIM.2013.05.004

7 January 2021

Identifiers

DOI

1 reference

29 November 2017

1 reference